Multiple myeloma in Latin America

Area of Science:

• Hematology
• Oncology
• Public Health

Background:

• Multiple myeloma (MM) in Latin America (LATAM) is characterized by resource limitations in low- and middle-income countries.
• These challenges impact various stages of patient care, from diagnosis to treatment.
• Understanding these regional disparities is critical for improving MM management.

Purpose of the Study:

• To provide a narrative review of multiple myeloma in Latin America.
• To discuss epidemiology, diagnostic methods, risk stratification, common medications, and treatment outcomes.
• To highlight challenges and suggest areas for improvement in MM care within the region.

Main Methods:

• Narrative review of existing literature and data on multiple myeloma in Latin America.
• Analysis of epidemiological trends, diagnostic accessibility, and therapeutic options.
• Evaluation of treatment outcomes and challenges in resource-limited settings.

Main Results:

• Patients in LATAM are frequently diagnosed at advanced stages of multiple myeloma.
• Access to advanced diagnostic studies and risk evaluations is often inadequate.
• Treatment options are frequently limited, with restricted access to autologous stem cell transplantation.

Conclusions:

• Significant efforts are required at national health system levels to enhance MM diagnosis, risk stratification, and treatment in LATAM.
• Collaborative initiatives among regional groups are underway to address the challenges in MM care.
• Improving resource allocation and access to care is essential to offer MM patients a better chance of improved outcomes.